Literature DB >> 10321533

Diabetic macular edema: risk factors and concomitants.

J M Lopes de Faria1, A E Jalkh, C L Trempe, J W McMeel.   

Abstract

PURPOSE: To investigate the systemic and ocular factors associated with diffuse macular edema in patients with diabetic retinopathy (DR) and compare with patients with focal or no macular edema.
METHODS: From 160 consecutive patients with DR, we obtained medical and ocular histories, blood pressure and visual acuity. Macular edema was determined by biomicroscopy and stereoscopic fundus photography. Fluorescein angiography was used in the characterization of its leakage, and the vitreoretinal relationship was performed by preset lens biomicroscopy.
RESULTS: Among adult-onset diabetes mellitus (DM) patients, 55% had diffuse, 23.5% had focal and 21.5% had no macular edema (p=0.01). The risk of developing diffuse macular edema was 3.2 times greater in patients with high blood pressure (HBP) (95% confidence interval (CI), 1.5 to 6.9). Patients with cardiovascular disease (CVD) had a higher prevalence of diffuse (58.0%) than focal (26.0%) or no maculopathy (16.0%) (p=0.01). The odds for development of diffuse macular edema was 3.4 times greater in patients with vitreomacular adhesion (95% CI, 1.15 to 13.30) than in those with complete posterior vitreoretinal attachment or vitreoretinal separation. The odds for development of diffuse macular edema were 6.2 (95% CI, 1.83 to 21.04) and 7.7 times greater (95% CI, 3.12 to 19.12) in patients with PPDR and PDR, respectively, in comparison with those with NPDR.
CONCLUSIONS: In this study, adult-onset DM, HBP, CVD, vitreomacular adhesion and advanced retinopathy were associated with increased risk of development of diffuse diabetic macular edema.

Entities:  

Mesh:

Year:  1999        PMID: 10321533     DOI: 10.1034/j.1600-0420.1999.770211.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  28 in total

1.  Effect of grid laser photocoagulation in diffuse diabetic macular edema in correlation to glycosylated haemoglobin (HbA1c).

Authors:  Katharina E Schmid; Beatrix Neumaier-Ammerer; Ulrike Stolba; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-04-07       Impact factor: 3.117

Review 2.  Diabetic macular oedema: pathophysiology, management challenges and treatment resistance.

Authors:  Bobak Bahrami; Meidong Zhu; Thomas Hong; Andrew Chang
Journal:  Diabetologia       Date:  2016-05-14       Impact factor: 10.122

3.  Prediction, by retinal location, of the onset of diabetic edema in patients with nonproliferative diabetic retinopathy.

Authors:  Wendy W Harrison; Marcus A Bearse; Marilyn E Schneck; Brian E Wolff; Nicholas P Jewell; Shirin Barez; Andrew B Mick; Bernard J Dolan; Anthony J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-29       Impact factor: 4.799

4.  Diagnosing and monitoring diabetic macular edema: structural and functional tests.

Authors:  Edoardo Midena; Stela Vujosevic
Journal:  Int Ophthalmol       Date:  2012-05-23       Impact factor: 2.031

5.  Blood pressure, vessel caliber, and retinal thickness in diabetes.

Authors:  Wendy W Harrison; Ann Chang; Maria G Cardenas; Marcus A Bearse; Marilyn E Schneck; Shirin Barez; Anthony J Adams
Journal:  Optom Vis Sci       Date:  2012-12       Impact factor: 1.973

Review 6.  [Diabetic maculopathy].

Authors:  C Haritoglou; M Kernt; A Wolf
Journal:  Ophthalmologe       Date:  2015-10       Impact factor: 1.059

7.  Impact of estimated glomerular filtration rate on diabetic macular edema.

Authors:  Shreyas Temkar; Nishanthini Karuppaiah; Brijesh Takkar; Dipankar Bhowmik; Manjari Tripathi; Sivasubramanian Ramakrishnan; Yog Raj Sharma; Rajpal Vohra; Rohan Chawla; Pradeep Venkatesh
Journal:  Int Ophthalmol       Date:  2017-05-18       Impact factor: 2.031

8.  Prospective microperimetry and OCT evaluation of efficacy of repeated intravitreal bevacizumab injections for persistent clinically significant diabetic macular edema.

Authors:  Romualdo Malagola; Giovanni Spinucci; Carmela Cofone; Luigi Pattavina
Journal:  Int Ophthalmol       Date:  2012-12-14       Impact factor: 2.031

9.  Plasminogen kringle 5 reduces vascular leakage in the retina in rat models of oxygen-induced retinopathy and diabetes.

Authors:  S X Zhang; J Sima; C Shao; J Fant; Y Chen; B Rohrer; G Gao; J-x Ma
Journal:  Diabetologia       Date:  2003-12-10       Impact factor: 10.122

10.  Bevacizumab for the management of diabetic macular edema.

Authors:  Francisco Rosa Stefanini; J Fernando Arevalo; Maurício Maia
Journal:  World J Diabetes       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.